E-cadherin expression and prognosis of head and neck squamous cell carcinoma: evidence from 19 published investigations
- PMID: 27217768
- PMCID: PMC4853145
- DOI: 10.2147/OTT.S98577
E-cadherin expression and prognosis of head and neck squamous cell carcinoma: evidence from 19 published investigations
Abstract
Objective: The objective of this study was to review the published literature and investigate whether E-cadherin gene is a prognostic factor in head and neck squamous cell carcinoma by conducting a meta-analysis.
Methods: Studies were identified from the databases Embase, Medline, and Cochrane Library by using the keywords "E-cadherin gene" and "head and neck cancer". Overall survival (OS) and disease-free survival (DFS) were the primary outcome measurements.
Results: Our literature review identified 1,458 articles; 19 studies with a total number of 2,012 cases were eligible for inclusion in the meta-analysis. The hazard ratio (HR) for OS of patients with decreased expression of E-cadherin gene was 0.57 (95% CI =0.37, 0.89; P=0.000). However, statistical heterogeneity was unacceptably high (I (2)=74.5%, P=0.000). After sensitivity analysis, heterogeneity became acceptable, and the effect measure was still significant (I (2)=7.0%; HR =0.52; 95% CI =0.40, 0.66; P=0.000). The HR for DFS was 0.53 (95% CI =0.42, 0.67; P=0.000).
Conclusion: This meta-analysis showed clear evidence that high E-cadherin gene expression is a positive prognostic factor of head and neck squamous cell carcinoma, resulting in better OS and DFS. However, this conclusion must be interpreted with caution due to a few limitations.
Keywords: E-cadherin gene; head and neck squamous cell carcinoma; immunohistochemistry; prognosis.
Figures





Similar articles
-
Sex determining region Y-box 2 is a prognostic factor for head and neck squamous cell carcinoma: Evidence from 11 published investigations.J Cancer Res Ther. 2020 Apr-Jun;16(3):434-439. doi: 10.4103/0973-1482.189238. J Cancer Res Ther. 2020. PMID: 32719247
-
The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis.Oral Oncol. 2018 Nov;86:81-90. doi: 10.1016/j.oraloncology.2018.09.016. Epub 2018 Sep 17. Oral Oncol. 2018. PMID: 30409325
-
The Role of E-Cadherin as a Prognostic Biomarker in Head and Neck Squamous Carcinoma: A Systematic Review and Meta-Analysis.Mol Diagn Ther. 2018 Oct;22(5):523-535. doi: 10.1007/s40291-018-0351-y. Mol Diagn Ther. 2018. PMID: 30006812
-
Differential impact of circulating tumor cells on disease recurrence and survivals in patients with head and neck squamous cell carcinomas: An updated meta-analysis.PLoS One. 2018 Sep 7;13(9):e0203758. doi: 10.1371/journal.pone.0203758. eCollection 2018. PLoS One. 2018. PMID: 30192876 Free PMC article.
-
Impact of pretherapeutic neutrophil-to-lymphocyte ratio, serum albumin, body-mass index, and advanced lung cancer inflammation index on clinical outcome in sinonasal squamous cell carcinoma.J Craniomaxillofac Surg. 2020 Jan;48(1):33-37. doi: 10.1016/j.jcms.2019.11.010. Epub 2019 Nov 27. J Craniomaxillofac Surg. 2020. PMID: 31810849
Cited by
-
The role of cell adhesion molecules in the progression of bladder urothelial carcinomas.Rom J Morphol Embryol. 2022 Jan-Mar;63(1):145-151. doi: 10.47162/RJME.63.1.15. Rom J Morphol Embryol. 2022. PMID: 36074678 Free PMC article.
-
Gene-Expression Patterns of Tumor and Peritumor Tissues of Smoking and Non-Smoking HPV-Negative Patients with Head and Neck Squamous Cell Carcinoma.Biomedicines. 2024 Mar 21;12(3):696. doi: 10.3390/biomedicines12030696. Biomedicines. 2024. PMID: 38540309 Free PMC article.
-
Assessment of epithelial-mesenchymal transition signatures in oral submucous fibrosis.J Oral Maxillofac Pathol. 2019 May-Aug;23(2):308. doi: 10.4103/jomfp.JOMFP_177_18. J Oral Maxillofac Pathol. 2019. PMID: 31516252 Free PMC article.
-
Explore, Visualize, and Analyze Functional Cancer Proteomic Data Using the Cancer Proteome Atlas.Cancer Res. 2017 Nov 1;77(21):e51-e54. doi: 10.1158/0008-5472.CAN-17-0369. Cancer Res. 2017. PMID: 29092939 Free PMC article.
-
Hallmarks of Cancer Applied to Oral and Oropharyngeal Carcinogenesis: A Scoping Review of the Evidence Gaps Found in Published Systematic Reviews.Cancers (Basel). 2022 Aug 8;14(15):3834. doi: 10.3390/cancers14153834. Cancers (Basel). 2022. PMID: 35954497 Free PMC article.
References
-
- Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. - PubMed
-
- Silverman S., Jr Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge. J Am Dent Assoc. 2001;132(suppl):7S–11S. - PubMed
-
- Ren ZH, Wu HJ, Zhang S, et al. A new surgical strategy for treatment of tongue squamous cell carcinoma based on anatomic study with preliminary clinical evaluation. J Craniomaxillofac Surg. 2015;43:1577–1582. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources